| Antigen-and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice D Kolodin, N van Panhuys, C Li, AM Magnuson, D Cipolletta, CM Miller, ... Cell metabolism 21 (4), 543-557, 2015 | 348 | 2015 |
| Immune homeostasis enforced by co-localized effector and regulatory T cells Z Liu, MY Gerner, N Van Panhuys, AG Levine, AY Rudensky, RN Germain Nature 528 (7581), 225-230, 2015 | 327 | 2015 |
| T-cell-receptor-dependent signal intensity dominantly controls CD4+ T cell polarization in vivo N Van Panhuys, F Klauschen, RN Germain Immunity 41 (1), 63-74, 2014 | 284 | 2014 |
| Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance DC Palmer, GC Guittard, Z Franco, JG Crompton, RL Eil, SJ Patel, Y Ji, ... Journal of Experimental Medicine 212 (12), 2095-2113, 2015 | 188 | 2015 |
| In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation N van Panhuys, SC Tang, M Prout, M Camberis, D Scarlett, J Roberts, ... Proceedings of the National Academy of Sciences 105 (34), 12423-12428, 2008 | 160 | 2008 |
| Basophils are the major producers of IL-4 during primary helminth infection N Van Panhuys, M Prout, E Forbes, B Min, WE Paul, G Le Gros The Journal of Immunology 186 (5), 2719-2728, 2011 | 125 | 2011 |
| TCR signal strength alters T–DC activation and interaction times and directs the outcome of differentiation N Van Panhuys Frontiers in immunology 7, 168859, 2016 | 116 | 2016 |
| Collapse of the tumor stroma is triggered by IL-12 induction of Fas SP Kerkar, AJ Leonardi, N Van Panhuys, L Zhang, Z Yu, JG Crompton, ... Molecular Therapy 21 (7), 1369-1377, 2013 | 76 | 2013 |
| NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ–IL-27 axis WP Chong, N van Panhuys, J Chen, PB Silver, Y Jittayasothorn, ... Journal of Experimental Medicine 212 (10), 1739-1752, 2015 | 71 | 2015 |
| Effector lymphoid tissue and its crucial role in protective immunity N van Panhuys, R Perret, M Prout, F Ronchese, G Le Gros Trends in immunology 26 (5), 242-247, 2005 | 54 | 2005 |
| Epigenetic regulation of Th2 cytokine expression in atopic diseases N Van Panhuys, G Le Gros, MJ McConnell Tissue Antigens 72 (2), 91-97, 2008 | 47 | 2008 |
| Differential requirements for IL‐4/STAT6 signalling in CD4 T‐cell fate determination and Th2‐immune effector responses E Forbes, N Van Panhuys, B Min, G Le Gros Immunology and cell biology 88 (3), 240-243, 2010 | 46 | 2010 |
| The future of immunoimaging—deeper, bigger, more precise, and definitively more colorful J Tang, N van Panhuys, W Kastenmüller, RN Germain European journal of immunology 43 (6), 1407-1412, 2013 | 38 | 2013 |
| Quantifying in situ adaptive immune cell cognate interactions in humans VM Liarski, A Sibley, N van Panhuys, J Ai, A Chang, D Kennedy, ... Nature immunology 20 (4), 503-513, 2019 | 34 | 2019 |
| Blimp-1 induced by IL-4 plays a critical role in suppressing IL-2 production in activated CD4 T cells L Wang, N Van Panhuys, J Hu-Li, S Kim, G Le Gros, B Min The Journal of Immunology 181 (8), 5249-5256, 2008 | 27 | 2008 |
| Immature murine NKT cells pass through a stage of developmentally programmed innate IL-4 secretion N Dickgreber, KJ Farrand, N van Panhuys, DA Knight, SJ McKee, ... Journal of leukocyte biology 92 (5), 999-1009, 2012 | 23 | 2012 |
| Microbial dysbiosis tunes the immune response towards allergic disease outcomes T Augustine, M Kumar, S Al Khodor, N van Panhuys Clinical Reviews in Allergy & Immunology 65 (1), 43-71, 2023 | 17 | 2023 |
| Allergen-induced CD4+ T cell cytokine production within airway mucosal dendritic cell–T cell clusters drives the local recruitment of Myeloid effector cells TZ Veres, T Kopcsányi, N van Panhuys, MY Gerner, Z Liu, P Rantakari, ... The Journal of Immunology 198 (2), 895-907, 2017 | 17 | 2017 |
| Studying dendritic cell-T cell interactions under in vivo conditions N van Panhuys The Immune Synapse: Methods and Protocols, 569-583, 2017 | 13 | 2017 |
| High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines D Rinchai, S Deola, G Zoppoli, BSA Kabeer, S Taleb, I Pavlovski, ... Science advances 8 (45), eabp9961, 2022 | 9 | 2022 |
